Actively Recruiting
Comparing Prophylactic Negative Pressure Wound Therapy and Standard Dressings in Breast Reduction Surgery
Led by Medstar Health Research Institute · Updated on 2025-10-27
92
Participants Needed
1
Research Sites
17 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the use of closed incision negative pressure wound therapy ciNPWT compared to standard adhesive dressings in women undergoing bilateral reduction mammaplasty. This randomized trial aims to compare wound complications, patient-reported outcomes, and cost differences between these two wound management methods. The study focuses on promoting wound healing and preventing postoperative issues after breast reduction surgery. Participants receive ciNPWT on one breast for up to 7 days after surgery to help wound healing, while the other breast receives the standard adhesive dressing as a control. This split-body design allows direct comparison between the two wound treatments on the same person. The ciNPWT device applies gentle negative pressure to the closed incision, whereas the standard dressing protects the wound during initial healing. During the study, researchers will monitor wound complications for 30 days post-surgery. They will also assess patient-reported pain at several time points up to 3 months, scar quality at 1 and 3 months, and satisfaction with breast appearance over 6 months. Costs related to dressings and healthcare resource use will be tracked for about 6 months. Participants will attend follow-up visits for these assessments and be monitored for safety throughout the trial.
CONDITIONS
Brief Title
NPWT Reduction Mammaplasty
Research Team
R
Ryan P Lin, MD
K
Kenneth L Fan, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here